Clinical Risk Grouping Solution Market Size & Competitors

The Clinical Risk Grouping Solution Market is driving significant change across healthcare enterprises, enabling organizations to enhance risk stratification, coordinate care more effectively, and align operations with evolving regulatory and reimbursement models. As demands for data-driven decisions intensify, senior leaders must evaluate solutions that provide both integration flexibility and robust compliance support.

Market Snapshot: Clinical Risk Grouping Solution Market

The Clinical Risk Grouping Solution Market expanded from USD 1.20 billion in 2025 to USD 1.38 billion in 2026, with projections indicating continued growth at a CAGR of 14.72% to reach USD 3.14 billion by 2032. This upward trajectory is underpinned by an industry-wide move toward value-based care, the adoption of advanced analytics, and a clear need for interoperable, transparent technology. Solutions appeal to payers, providers, and research organizations, each requiring integration with existing systems and support for clinical, operational, and financial insights.

Scope & Segmentation

Deployment Modes: Cloud options (hybrid, private, public) and on-premise models address diverse security, compliance, and infrastructure requirements across organizations.
Solution Types: Software-only offerings provide core analytics, while software and services bundles include implementation support and ongoing maintenance for seamless integration.
Payment Models: Fee-for-service and value-based care arrangements allow alignment of solution procurement with evolving healthcare delivery and reimbursement strategies.
Organization Sizes: Large enterprises prioritize centralized risk engines and advanced security, whereas small and medium enterprises seek scalable, ready-to-use solutions.
End Users: Hospitals, payers, and research institutes each present distinct workflow, evidence, and integration needs.
Regional Focus: The Americas demand high interoperability with legacy systems. Europe, Middle East, and Africa prioritize data localization and privacy, while Asia-Pacific emphasizes scalable analytics and cloud-based flexibility.

Key Takeaways for Senior Decision-Makers

Platforms have evolved beyond point solutions, now offering modular designs that support continuous patient insights and seamless integration with enterprise applications.
Transparent risk stratification logic and strong interoperability are central, assuring stakeholders auditable, consistent processes throughout the healthcare continuum.
Success is driven by phased deployment strategies that use outcome-based metrics for early validation and iterative improvement.
Procurement and deployment are shaped by local regulatory requirements, making investments in data privacy, localization, and regional partnership networks essential for compliance and operational relevance.
Vendor differentiation now focuses on open APIs, managed services, adaptable governance protocols, and rigorous validation practices to assure clinical reliability and operational efficiency.
Aligning technical capabilities with user needs and governance frameworks reduces adoption risks while optimizing value from these solutions.

Tariff Impact on Procurement and Supply Chain Resilience

Evolving tariff policies in the United States are influencing procurement choices for clinical risk grouping technologies. Higher tariffs on hardware and imported components drive both vendors and healthcare organizations to reassess deployment options, frequently opting for adaptable cloud-based or modular architectures to mitigate supply chain delays and control capital expenditure. Procurement teams also increasingly value diversified sourcing strategies to maintain continuity throughout regulatory changes.

Methodology & Data Sources

This research integrates structured interviews with clinical leaders, payer executives, and implementation experts. It includes comprehensive vendor assessments and reviews of regulatory policy materials. The analysis places particular emphasis on interoperability, deployment flexibility, technology explainability, and robust validation frameworks. Scenario-based analysis helps clarify supply chain and governance implications for stakeholders.

Why This Report Matters

Delivers segmented, actionable insights enabling effective technology investment and vendor selection in complex regulatory environments.
Supports clinical, procurement, and IT leaders in evaluating operational risk and selecting solutions that yield measurable improvements in care coordination and financial performance.
Clarifies critical regional and regulatory considerations to support optimal deployment strategies, partnership development, and sustainable technology adoption.

Conclusion

The successful adoption of clinical risk grouping technologies relies on transparency, interoperability, and alignment with organizational objectives. Senior leaders should integrate regulatory, operational, and segment-specific considerations into governance and procurement strategies to ensure sustained clinical and operational value.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Clinical Risk Grouping Solution Market, by Deployment Mode

8.1. Cloud
8.1.1. Hybrid Cloud
8.1.2. Private Cloud
8.1.3. Public Cloud
8.2. On Premise

9. Clinical Risk Grouping Solution Market, by Solution Type

9.1. Software And Services
9.1.1. Implementation Services
9.1.2. Support And Maintenance
9.2. Software Only

10. Clinical Risk Grouping Solution Market, by Payment Model

10.1. Fee For Service
10.2. Value Based Care

11. Clinical Risk Grouping Solution Market, by Organization Size

11.1. Large Enterprises
11.2. Small And Medium Enterprises

12. Clinical Risk Grouping Solution Market, by End User

12.1. Hospitals
12.2. Payers
12.3. Research Institutes

13. Clinical Risk Grouping Solution Market, by Region

13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific

14. Clinical Risk Grouping Solution Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. Clinical Risk Grouping Solution Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. United States Clinical Risk Grouping Solution Market
17. China Clinical Risk Grouping Solution Market

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. 3M Company
18.6. Allscripts Healthcare Solutions, Inc.
18.7. Cognizant Technology Solutions Corporation
18.8. Conduent, Inc.
18.9. Cotiviti, Inc.
18.10. Epic Systems Corporation
18.11. Evolent Health, Inc.
18.12. HBI Solutions, Inc.
18.13. Health Catalyst, Inc.
18.14. HMS Holdings Corp.
18.15. Lightbeam Health Solutions
18.16. Oracle Corporation
18.17. R1 RCM Inc.
18.18. UnitedHealth Group Incorporated

List of Figures

FIGURE 1. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOLUTION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PAYMENT MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY HYBRID CLOUD, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY HYBRID CLOUD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY HYBRID CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRIVATE CLOUD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PRIVATE CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PUBLIC CLOUD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PUBLIC CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ON PREMISE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ON PREMISE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOLUTION TYPE, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE AND SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE AND SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY IMPLEMENTATION SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY IMPLEMENTATION SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY IMPLEMENTATION SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SUPPORT AND MAINTENANCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SUPPORT AND MAINTENANCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SUPPORT AND MAINTENANCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE ONLY, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE ONLY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE ONLY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY FEE FOR SERVICE, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY FEE FOR SERVICE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY FEE FOR SERVICE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY VALUE BASED CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY VALUE BASED CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY VALUE BASED CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY LARGE ENTERPRISES, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY LARGE ENTERPRISES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY LARGE ENTERPRISES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SMALL AND MEDIUM ENTERPRISES, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SMALL AND MEDIUM ENTERPRISES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SMALL AND MEDIUM ENTERPRISES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PAYERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PAYERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PAYERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. AMERICAS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 59. AMERICAS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 60. AMERICAS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 61. AMERICAS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOLUTION TYPE, 2018-2032 (USD MILLION)
TABLE 62. AMERICAS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 63. AMERICAS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 64. AMERICAS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2018-2032 (USD MILLION)
TABLE 65. AMERICAS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 66. NORTH AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. NORTH AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 68. NORTH AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 69. NORTH AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOLUTION TYPE, 2018-2032 (USD MILLION)
TABLE 70. NORTH AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 71. NORTH AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 72. NORTH AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2018-2032 (USD MILLION)
TABLE 73. NORTH AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 74. LATIN AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. LATIN AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 76. LATIN AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 77. LATIN AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOLUTION TYPE, 2018-2032 (USD MILLION)
TABLE 78. LATIN AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 79. LATIN AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 80. LATIN AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2018-2032 (USD MILLION)
TABLE 81. LATIN AMERICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOLUTION TYPE, 2018-2032 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2018-2032 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 90. EUROPE CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. EUROPE CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 92. EUROPE CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 93. EUROPE CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOLUTION TYPE, 2018-2032 (USD MILLION)
TABLE 94. EUROPE CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 95. EUROPE CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 96. EUROPE CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2018-2032 (USD MILLION)
TABLE 97. EUROPE CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 98. MIDDLE EAST CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. MIDDLE EAST CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 100. MIDDLE EAST CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 101. MIDDLE EAST CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOLUTION TYPE, 2018-2032 (USD MILLION)
TABLE 102. MIDDLE EAST CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 103. MIDDLE EAST CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 104. MIDDLE EAST CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2018-2032 (USD MILLION)
TABLE 105. MIDDLE EAST CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 106. AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 108. AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 109. AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOLUTION TYPE, 2018-2032 (USD MILLION)
TABLE 110. AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 111. AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 112. AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2018-2032 (USD MILLION)
TABLE 113. AFRICA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOLUTION TYPE, 2018-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2018-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. ASEAN CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. ASEAN CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 125. ASEAN CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 126. ASEAN CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOLUTION TYPE, 2018-2032 (USD MILLION)
TABLE 127. ASEAN CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 128. ASEAN CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 129. ASEAN CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2018-2032 (USD MILLION)
TABLE 130. ASEAN CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 131. GCC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 132. GCC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 133. GCC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 134. GCC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOLUTION TYPE, 2018-2032 (USD MILLION)
TABLE 135. GCC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 136. GCC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 137. GCC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2018-2032 (USD MILLION)
TABLE 138. GCC CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. EUROPEAN UNION CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. EUROPEAN UNION CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 141. EUROPEAN UNION CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 142. EUROPEAN UNION CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOLUTION TYPE, 2018-2032 (USD MILLION)
TABLE 143. EUROPEAN UNION CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 144. EUROPEAN UNION CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 145. EUROPEAN UNION CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2018-2032 (USD MILLION)
TABLE 146. EUROPEAN UNION CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 147. BRICS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. BRICS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 149. BRICS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 150. BRICS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOLUTION TYPE, 2018-2032 (USD MILLION)
TABLE 151. BRICS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 152. BRICS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 153. BRICS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2018-2032 (USD MILLION)
TABLE 154. BRICS CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 155. G7 CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 156. G7 CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 157. G7 CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 158. G7 CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOLUTION TYPE, 2018-2032 (USD MILLION)
TABLE 159. G7 CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 160. G7 CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 161. G7 CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2018-2032 (USD MILLION)
TABLE 162. G7 CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 163. NATO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 164. NATO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 165. NATO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 166. NATO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOLUTION TYPE, 2018-2032 (USD MILLION)
TABLE 167. NATO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 168. NATO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 169. NATO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2018-2032 (USD MILLION)
TABLE 170. NATO CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 173. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 174. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 175. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOLUTION TYPE, 2018-2032 (USD MILLION)
TABLE 176. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 177. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 178. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2018-2032 (USD MILLION)
TABLE 179. UNITED STATES CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 180. CHINA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 181. CHINA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
TABLE 182. CHINA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
TABLE 183. CHINA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOLUTION TYPE, 2018-2032 (USD MILLION)
TABLE 184. CHINA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY SOFTWARE AND SERVICES, 2018-2032 (USD MILLION)
TABLE 185. CHINA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY PAYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 186. CHINA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY ORGANIZATION SIZE, 2018-2032 (USD MILLION)
TABLE 187. CHINA CLINICAL RISK GROUPING SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Clinical Risk Grouping Solution market report include:

3M Company
Allscripts Healthcare Solutions, Inc.
Cognizant Technology Solutions Corporation
Conduent, Inc.
Cotiviti, Inc.
Epic Systems Corporation
Evolent Health, Inc.
HBI Solutions, Inc.
Health Catalyst, Inc.
HMS Holdings Corp.
Lightbeam Health Solutions
Oracle Corporation
R1 RCM Inc.
UnitedHealth Group Incorporated

Table Information

Report Attribute	Details
No. of Pages	187
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 1.38 Billion
Forecasted Market Value ( USD ) by 2032	$ 3.14 Billion
Compound Annual Growth Rate	14.7%
Regions Covered	Global
No. of Companies Mentioned	15

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3432EUR$3,939USD£2,981GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3702EUR$4,249USD£3,215GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5018EUR$5,759USD£4,358GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6073EUR$6,969USD£5,273GBP

Clinical Risk Grouping Solution Market - Global Forecast 2026-2032

Market Snapshot: Clinical Risk Grouping Solution Market

Scope & Segmentation

Key Takeaways for Senior Decision-Makers

Tariff Impact on Procurement and Supply Chain Resilience

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Market Snapshot: Clinical Risk Grouping Solution Market

Scope & Segmentation

Key Takeaways for Senior Decision-Makers

Tariff Impact on Procurement and Supply Chain Resilience

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Clinical Risk Grouping Solutions - Global Strategic Business Report

Clinical Risk Grouping Solution Market Report 2025

2025 Global Forecast for Clinical Risk Grouping Solutions Market (2026-2031 Outlook)-High Tech Outlook Report

Healthcare Analytics Market - Global Forecast 2026-2032

Big Data in Healthcare Market - Global Forecast 2026-2032

About the Clinical Risk Grouping Solutions Market